Drug Database
RU

Ruibosheng (PLEB001 / Ruibosheng / PLEB 001)

✓ Approved

Platinumlife Biotechnology (Beijing) · Cell-based Therapies · Cell-based Therapies

What is Ruibosheng?

Ruibosheng is a cell-based therapies developed by Platinumlife Biotechnology (Beijing). It is approved for therapeutic indications.

Drug Profile

Brand NamesPLEB001, Ruibosheng, PLEB 001
CompanyPlatinumlife Biotechnology (Beijing)
Drug ClassCell-based Therapies
StatusApproved
Sources: ClinicalTrials.gov, Platinumlife Biotechnology (Beijing)

Therapeutic Indications

Ruibosheng is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Immune system disordersChronic graft versus host disease✓ Approved

Ask about Ruibosheng